Yun Xiang Zhu
Corporate Officer/Principal at CANBRIDGE PHARMACEUTICALS INC.
Profile
Yun Xiang Zhu is currently the Vice President & Head-Global Research at CANbridge Pharmaceuticals Inc. Prior to this, he was the Senior Vice President at Shenogen Pharma Group Ltd.
from 2018 to 2020 and the Senior Director at Genzyme Corp.
from 2001 to 2018.
He also worked as a Research Associate at Fudan University from 1988 to 1990.
Dr. Zhu received his undergraduate degree from Zhejiang University in 1984, his graduate degree from Shanghai Institute of Materia Medica Chinese Academy of Sci in 1988, and his doctorate from The University of Miami Leonard M.
Miller School of Medicine in 1996.
Yun Xiang Zhu active positions
| Companies | Position | Start |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Corporate Officer/Principal | 2020-09-14 |
Former positions of Yun Xiang Zhu
| Companies | Position | End |
|---|---|---|
Shenogen Pharma Group Ltd.
 Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Shenogen Pharma Group Ltd. manufactures pharmaceutical products. It develops therapeutics for cancer treatment. The firm’s product pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. The company was founded by Kun Meng, Jing Li, Karen Liu and Zhaoyi Wang in 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 2020-08-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2018-04-30 |
| Fudan University | Corporate Officer/Principal | 1990-07-31 |
Training of Yun Xiang Zhu
| Zhejiang University | Undergraduate Degree |
| Shanghai Institute of Materia Medica Chinese Academy of Sci | Graduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Shenogen Pharma Group Ltd.
Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Shenogen Pharma Group Ltd. manufactures pharmaceutical products. It develops therapeutics for cancer treatment. The firm’s product pipeline consists of novel small molecule and antibody therapeutics for cancer treatment which includes liver cancer, breast cancer, other solid tumors and leukemia. The company was founded by Kun Meng, Jing Li, Karen Liu and Zhaoyi Wang in 2006 and is headquartered in Beijing, China. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Yun Xiang Zhu
